Single-dose Janssen COVID vaccine 66% effective in phase 3 trial
Results from a phase 3 clinical trial have shown the Janssen COVID-19 vaccine, which is part of the ...
Novovax COVID vaccine shown to be 89.3% effective in phase 3 trials
The Novovax COVID-19 vaccine, which the UK government has pre-ordered 60m doses of, has been shown t...
BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths
More than 100,000 people have now died from COVID-19 in the UK, five times the death toll that the U...
Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar
Loss of taste and smell and neurological aspects of 'long COVID' infection will be covered in a fort...
Increase cancer tests in primary care during pandemic, suggests NHS England
Local health systems should look to provide more cancer diagnostics in primary care during the pande...
Former Brexit secretary backs vitamin D supplements to beat COVID-19
The NHS should provide 10 times the current daily recommended amount of vitamin D to patients at inc...
GPs can give COVID and flu jabs at same time, says NHS England
GPs can now administer COVID-19 and flu jabs at the same time, according to updated guidance from NH...
GPs switch to practice-level COVID-19 vaccination drive to boost uptake
GPs are administering COVID-19 vaccines at individual practices to boost uptake among vulnerable pat...
Mixing of COVID-19 vaccines 'extremely unlikely', NHS England tells MPs
Patients are 'extremely unlikely' to be offered a first and second dose of different COVID-19 vaccin...
How will COVID-19 mass vaccination sites in England work?
The first mass vaccination sites in England open their doors this week. GPonline explains how the ne...
